The effect of non-oncology drugs on clinical and genomic risk in early luminal breast cancer.
Waissengrin B, Zahavi T, Salmon-Divon M, Goldberg A, Wolf I, Rubinek T, Winkler T, Farkash O, Grinshpun A, Zubkov A, Khatib M, Shachar SS, Keren N, Carmi-Levy I, Ben-David U, Sonnenblick A.
Waissengrin B, et al. Among authors: salmon divon m.
ESMO Open. 2022 Dec;7(6):100648. doi: 10.1016/j.esmoop.2022.100648. Epub 2022 Nov 30.
ESMO Open. 2022.
PMID: 36462463
Free PMC article.